HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaojun Liu Selected Research

Leukemia

5/2014Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapy.
8/2013Regimen-specific effects of RNA-modified chimeric antigen receptor T cells in mice with advanced leukemia.
12/2011Treatment of advanced leukemia in mice with mRNA engineered T cells.
10/2006Structural features in carrageenan that interact with a heparin-binding hematopoietic growth factor and modulate its biological activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaojun Liu Research Topics

Disease

79Neoplasms (Cancer)
10/2022 - 09/2007
11Neoplasm Metastasis (Metastasis)
05/2021 - 09/2010
10Body Weight (Weight, Body)
01/2020 - 11/2013
10Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 08/2005
8Carcinogenesis
01/2021 - 12/2013
8Stomach Neoplasms (Stomach Cancer)
12/2017 - 03/2013
7Inflammation (Inflammations)
02/2022 - 09/2012
7Myocardial Infarction
02/2022 - 10/2009
6Cardiovascular Diseases (Cardiovascular Disease)
03/2021 - 06/2007
6Vascular Diseases (Vascular Disease)
01/2020 - 06/2007
5Heart Failure
01/2022 - 01/2018
5Atherosclerosis
01/2022 - 06/2007
5Ovarian Neoplasms (Ovarian Cancer)
03/2021 - 01/2018
5Insulin Resistance
01/2019 - 09/2015
4Hypoxia (Hypoxemia)
02/2022 - 05/2016
4Thrombosis (Thrombus)
02/2021 - 11/2011
4Chromosome Aberrations (Chromosome Abnormalities)
12/2019 - 08/2005
4Lung Neoplasms (Lung Cancer)
07/2019 - 11/2014
4Pathologic Processes
03/2017 - 09/2012
4Lymphatic Metastasis
12/2016 - 09/2010
4Ischemia
06/2014 - 10/2009
4Leukemia
05/2014 - 10/2006
3Wounds and Injuries (Trauma)
06/2022 - 05/2012
3Hemorrhage
06/2022 - 11/2016
3Necrosis
02/2022 - 04/2010
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 09/2015
3Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 01/2019
3Hepatocellular Carcinoma (Hepatoma)
04/2020 - 01/2016
3Breast Neoplasms (Breast Cancer)
01/2020 - 01/2011
3Obesity
10/2018 - 09/2015
3Hypertension (High Blood Pressure)
01/2018 - 06/2007
3Mouth Neoplasms (Oral Cancer)
03/2014 - 09/2010
3Heart Diseases (Heart Disease)
08/2010 - 06/2007
2Coronary Artery Disease (Coronary Atherosclerosis)
10/2022 - 02/2017
2Renal Cell Carcinoma (Grawitz Tumor)
05/2022 - 01/2017
2Pain (Aches)
04/2022 - 02/2014
2Prostatic Neoplasms (Prostate Cancer)
01/2022 - 02/2010
2Carcinoma (Carcinomatosis)
01/2022 - 10/2017
2COVID-19
01/2022 - 01/2021
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 01/2021
2Atrial Fibrillation
12/2020 - 12/2018
2Neuroblastoma
01/2020 - 11/2014
2Fibrosis (Cirrhosis)
10/2019 - 01/2015

Drug/Important Bio-Agent (IBA)

20MicroRNAs (MicroRNA)IBA
01/2021 - 06/2007
13Proteins (Proteins, Gene)FDA Link
02/2022 - 07/2007
12Pharmaceutical PreparationsIBA
01/2021 - 01/2009
12Chimeric Antigen ReceptorsIBA
12/2017 - 11/2010
9Glucose (Dextrose)FDA LinkGeneric
02/2022 - 08/2011
9RNA (Ribonucleic Acid)IBA
01/2022 - 11/2010
9Messenger RNA (mRNA)IBA
01/2021 - 11/2010
9Biomarkers (Surrogate Marker)IBA
07/2020 - 09/2010
82'- cyano- 2'- deoxyarabinofuranosylcytosineIBA
12/2019 - 08/2005
6Long Noncoding RNAIBA
01/2022 - 08/2018
6Biological ProductsIBA
01/2021 - 06/2009
6DNA (Deoxyribonucleic Acid)IBA
01/2020 - 07/2007
6EnzymesIBA
07/2019 - 09/2007
5Triglycerides (Triacylglycerol)IBA
10/2018 - 08/2011
5NucleosidesIBA
01/2018 - 01/2008
4AntigensIBA
01/2021 - 11/2010
4Therapeutic UsesIBA
04/2020 - 11/2011
4AntioxidantsIBA
01/2020 - 09/2012
4pevonedistatIBA
07/2019 - 01/2017
4AntibodiesIBA
05/2019 - 07/2013
4sapacitabineIBA
01/2018 - 04/2012
4ProdrugsIBA
01/2018 - 04/2012
3Circular RNAIBA
10/2022 - 01/2019
3Anti-Bacterial Agents (Antibiotics)IBA
04/2022 - 10/2021
3Small Interfering RNA (siRNA)IBA
03/2021 - 03/2014
3RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2021 - 09/2012
3Ligases (Synthetase)IBA
01/2020 - 03/2019
3Interleukin-6 (Interleukin 6)IBA
01/2020 - 12/2013
3Oxygen (Dioxygen)IBA
01/2018 - 11/2007
3Reactive Oxygen Species (Oxygen Radicals)IBA
06/2014 - 07/2009
3shexiang baoxinIBA
03/2014 - 09/2012
2oxidized low density lipoproteinIBA
10/2022 - 01/2017
2Hemostatics (Antihemorrhagics)IBA
06/2022 - 11/2016
2Interleukin-10 (Interleukin 10)IBA
04/2022 - 10/2021
2HMGB1 Protein (HMG1)IBA
02/2022 - 05/2012
2InflammasomesIBA
02/2022 - 01/2019
2Complement System Proteins (Complement)IBA
01/2022 - 11/2010
2CytokinesIBA
10/2021 - 01/2020
2Polysaccharides (Glycans)IBA
10/2021 - 01/2021
2Glutamic Acid (Glutamate)FDA Link
10/2021 - 05/2012
2PolymersIBA
02/2021 - 07/2020
2Hormones (Hormone)IBA
01/2021 - 02/2010
2Silicon Dioxide (Silica)FDA LinkGeneric
01/2021 - 05/2018
2MicellesIBA
11/2020 - 07/2020
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 01/2020
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 06/2015
2C-Reactive ProteinIBA
01/2020 - 06/2012
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2020 - 01/2017
2Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 12/2018
2Fluorescent Dyes (Fluorescent Probes)IBA
11/2019 - 11/2011
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2019 - 11/2017

Therapy/Procedure

17Therapeutics
05/2022 - 08/2005
7Drug Therapy (Chemotherapy)
04/2020 - 08/2013
5Immunotherapy
01/2021 - 11/2014
3Electrodes (Electrode)
01/2021 - 01/2018
3Aftercare (After-Treatment)
01/2019 - 10/2009
2Precision Medicine
01/2021 - 01/2016